$1.34
Value $141M
DH and INTC stock compared: price, dividend, valuation and results, from SEC filings.
$1.34
Value $141M
$55.84
Value $297B
Definitive Healthcare (DH) has a market value of $141M and Intel (INTC) $297B. Over the last year, with dividends, DH moved -50.7% and INTC +57.7%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
DH$141M
INTC$297B
INTC is 2,112 times DH
Revenue, 12 months
DH$227M
INTC$59.9B
INTC is 263 times DH
Net income, 12 months
DH-$157M
INTC-$12.0B
Operating margin
DH-105.4%
INTC2.9%
108.3 points apart
ROIC
DH-44.0%
INTC0.9%
44.9 points apart
P/E
DH–
INTC–
Dividend yield
DH0.0%
INTC0.0%
About the same
5-year return
DH-96.9%
INTC+20.1%
117.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
DH-96.9%
INTC+20.1%
| Period | DHWith dividends | INTCWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | -50.7%Price -50.7% | +57.7%Price +57.7% |
| 3 years since November 16, 2023 | -83.1%-44.7% a yearPrice -83.1% | +31.0%+9.4% a yearPrice +29.3% |
| 5 years since November 15, 2021 | -96.9%-50.2% a yearPrice -96.9% | +20.1%+3.7% a yearPrice +11.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
DHDefinitive HealthcareINTCIntel
| Price | $1.34 | $55.84 |
|---|---|---|
| Market value | $141M | $297B |
| Enterprise value (EV) | $109M | $293B |
| P/E | – | – |
| P/E, 5-year median | – | – |
| P/B | 0.8 | 2.6 |
| EV/EBIT | – | 166.2 |
| Free cash flow yield | 17.2% | 1.3% |
| Revenue, 12 months | $227M | $59.9B |
|---|---|---|
| Net income, 12 months | -$157M | -$12.0B |
| Free cash flow, 12 months | $24M | $3.8B |
| Earnings per share, 12 months | -$1.51 | -$2.42 |
| Revenue growth, year on year | -4.2% | -0.5% |
| Revenue growth a year, past | +15.3%over 5 years | -7.5%over 5 years |
| EPS growth a year, past | – | – |
| Gross margin | 75.4% | 39.9% |
|---|---|---|
| Operating margin | -105.4% | 2.9% |
| Net margin | -69.2% | -20.1% |
| ROIC | -44.0% | 0.9% |
| ROE | -58.9% | -11.3% |
| Cash | $190M | $54.0B |
|---|---|---|
| Total debt | $164M | $50.1B |
| Net debt / EBITDA | – | -0.3 |
| Interest cover | -22.2× | 1.5× |
| Dividend yield | – | – |
|---|---|---|
| Dividend per share, 12 months | – | – |
| Dividend growth a year, past | – | – |
| Buyback yield | 35.2% | – |
| Shareholder yield | 35.2% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Intel ($297B) is about 2,112.0 times Definitive Healthcare ($141M), at today's prices.
Since November 15, 2021, DH's price moved -96.9% and INTC's +11.3%. With dividends: DH -96.9% (-50.2% a year), INTC +20.1% (+3.7% a year). Past returns do not predict future ones.
Neither paid a dividend over the last twelve months: Definitive Healthcare and Intel return money to shareholders, if they do, in other ways, such as buybacks.
Over the last twelve months, the net margin was -69.2% for Definitive Healthcare and -20.1% for Intel, and the operating margin -105.4% and 2.9%. Revenue was $227M and $59.9B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.